Genetic Therapy's P2P Acquisition

Genetic Therapy raised a round of funding on July 11, 1995. Investors include Sandoz.

Genetic Therapy is a leading gene-therapy company working on treatments for cancer, AIDS, cystic fibrosis, hemophilia and Gaucher's disease, an inherited enzyme deficiency disorder.…

Articles about Genetic Therapy's P2P Acquisition: